Robert P. Schwartz, M.D.
Senior Research Scientist
M.D., University of Padua, Italy
Phone: 410-837-3977 ext. 276
Dr. Schwartz, a Senior Research Scientist at FRI, is a psychiatrist and former Director of the Division of Alcohol and Drug Abuse in the Department of Psychiatry at the University of Maryland School of Medicine. His research interests include entry and engagement in drug abuse treatment, treatment of opioid dependence in community and in criminal justice settings, and screening and brief intervention for drug misuse in primary care settings. He has served as Principal Investigator (PI) of numerous National Institute on Drug Abuse (NIDA) funded clinical trials. Currently, Dr. Schwartz is PI of studies of implementing interim methadone treatment, piloting pharmacy-based methadone treatment, and creating an addiction medicine practice-based research network. He is also Multi-PI with Dr. George Bigelow from Johns Hopkins University of the Mid-Atlantic Node of the NIDA Clinical Trials Network. He has over 200 scientific publications, is the winner of the Dole-Nyswander Award from the American Association for the Treatment of Opioid Dependence, and served as the Chair of the Substance Abuse and Mental Health Services Administration’s Toolkit for Improving Practice (TIP #63) on Medications for the Treatment of Opioid Use Disorder.